Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus
- 230 Downloads
Older HIV-infected men are at higher risk for both depression and cognitive impairments, compared to HIV-uninfected men. We evaluated the association between longitudinal patterns of depressive symptoms and attention/executive function in HIV-infected and HIV-uninfected men aged 50+ years to understand whether HIV infection influenced the long-term effect of depression on attention/executive function. Responses to the Center for Epidemiologic Studies—Depression scale and attention/executive function tests (Trail Making Test Part B and Symbol Digit Modalities Test) were collected semiannually from May 1986 to April 2015 in 1611 men. Group-based trajectory models, stratified by HIV status, were used to identify latent patterns of depressive symptoms and attention/executive function across 12 years of follow-up. We identified three depression patterns for HIV-infected and HIV-uninfected men (rare/never 50.0 vs. 60.6%, periodically depressed 29.6 vs. 24.5%, chronic high 20.5 vs.15.0%, respectively) and three patterns of attention/executive function for HIV-infected and HIV-uninfected men (worst-performing 47.4 vs. 45.1%; average 41.9 vs. 47.0%; best-performing 10.7 vs. 8.0%, respectively). Multivariable logistic regression models were used to assess associations between depression patterns and worst-performing attention/executive function. Among HIV-uninfected men, those in the periodically depressed and chronic high depressed groups had higher odds of membership in the worst-performing attention/executive function group (adjusted odds ratio [AOR] = 1.45, 95% CI 1.04, 2.03; AOR = 2.25, 95% CI 1.49, 3.39, respectively). Among HIV-infected men, patterns of depression symptoms were not associated with patterns of attention/executive function. Results suggest that HIV-uninfected, but not HIV-infected, men with chronic high depression are more likely to experience a long-term pattern of attention/executive dysfunction.
KeywordsDepression Human immunodeficiency virus Aging Attention/executive function
The authors would like to thank all MACS participants and Alden Gross and Ms. Natalie Kelso for their expertise.
Compliance with ethical standards
The study protocol was approved at all collaborating institutions’ IRBs, and participants provided written informed consent.
This study was supported by the National Institutes of Health (1R03MH10396-01). An additional source of support for MACS included the Center for AIDS Research, Johns Hopkins University (P30AI094189). NMA was supported by fellowship from the Epidemiology and Biostatistics of Aging Training Grant (5T32AG000247).
Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS): MACS (principal investigators): Johns Hopkins University Bloomberg School of Public Health (Joseph Margolick), U01-AI35042; Northwestern University (Steven Wolinsky), U01-AI35039; University of California, Los Angeles (Roger Detels), U01-AI35040; University of Pittsburgh (Charles Rinaldo), U01-AI35041; and the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health (Lisa Jacobson), UM1-AI35043. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR001079 (JHU ICTR) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.
Role of funder/sponsor
The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH), Johns Hopkins ICTR, or NCATS. The MACS website is located at http://aidscohortstudy.org/.
Conflict of interest
The authors declare that they have no conflicts of interest.
- Becker J, Kingsley LA, Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Selnes OA (2014) Cohort profile: recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study. Int J Epidemiol: 1–11Google Scholar
- Campos L, Guimaraes M, Remien R (2008) Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav 14Google Scholar
- Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK (2002) Demographic characteristics and normative observations for derived-trail making test indices. Cogn Behav Neurol 15:39–43Google Scholar
- Gonzalez JS, Batchelder AW, Psaros C, Safren SA (2011) Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr 58 doi: 10.1097/QAI.0b013e31822d490a
- Heaton R, Clifford D, Franklin D, Woods S, Ake C, Vaida F, Ellis R, Letendre S, Marcotte T, Atkinson J, Rivera-Mindt M, Vigil O, Taylor M, Collier A, Marra C, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan J, Abramson I, Gamst A, Fennema-Notestine C, Jernigan T, Wong J, Grant I, For the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–2096CrossRefPubMedPubMedCentralGoogle Scholar
- Heaton R, Franklin D, Ellis R, McCutchan J, Letendre S, LeBlanc S, Corkran S, Duarte N, Clifford D, Woods S, Collier A, Marra C, Morgello S, Mindt MR, Taylor M, Marcotte T, Atkinson JH, Wolfson T, Gelman B, McArthur J, Simpson D, Abramson I, Gamst A, Fennema-Notestine C, Jernigan T, Wong J, Grant I, For the CHARTER and HNRC Groups (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3–16Google Scholar
- Horberg M, Silverberg M, Hurley L, Towner W, Klein D, Bersoff-Matcha S, Weinberg W, Antoniskis D, Mogyoros M, Dodge W, Dobrinich R, Quesenberry C, Kovach D (2008) Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 47:384–390CrossRefPubMedGoogle Scholar
- Ironson G, O’Cleirigh C, Fletcher M, Laurenceau J, Balbin E, Klimas N, Schneiderman N, Solomon G (2005) Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 67:1013–1021CrossRefPubMedPubMedCentralGoogle Scholar
- Murphy R, Hagaman A, Reinders I, Steeves J, Newman A, Rubin S, Satterfield S, Kritchevsky S, Yaffe K, Ayonayon H, Nagin D, Simonsick E, Penninx B, Harris T, For the Health ABC Study (2015) Depressive trajectories and risk of disability and mortality in older adults: longitudinal findings from the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci: 1–8Google Scholar
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 30 Dec 2016.
- R Core Team (2015) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
- Rawlings AM, Sharrett AR, Schneider ALC, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E (2014) Diabetes in midlife and cognitive change over 20 years: the Atherosclerosis Risk in Communities Neurocognitive Study. Ann Intern Med 161:785–793CrossRefPubMedPubMedCentralGoogle Scholar
- Sacktor N, Bacellar H, Hoover D, Nance-Sproson T, Selnes O, Miller E, Pan GD, Kleeberger C, Brown A, Saah A, McArthur J (1996) Psychomotor slowing in HIV infection: a predictor of dementia, AIDS, and death. J Neuro-Oncol 2:404–410Google Scholar
- Sacktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin E, Miller EN (2010) Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neuro-Oncol 16:335–341Google Scholar
- Sanchez-Cubillo I, Perianez J, Adrover-Roig D, Rodriguez-Sanchez J, Rios-Lago M, Tirapu J, Barcelo F (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 15:438CrossRefPubMedGoogle Scholar
- SAS Institute Inc (2002-2004) SAS 9.1.3. SAS Institute Inc., CaryGoogle Scholar
- Selnes OA, Miller EN (1994) Development of a screening battery for HIV-related cognitive impairment: the MACS experience. In: Grant I, Martin A (eds) Neuropsychology of HIV infection. Oxford University Press, Inc., New York, pp 176–187Google Scholar
- Smith A (ed) (1968) The symbol-digit modalities test: a neuropsychologic test of learning and other cerebral disorders. Special Child Publications, SeattleGoogle Scholar
- StataCorp (2013) Stata Statistical Software: Release 13. StataCorp LP, College StationGoogle Scholar
- Substance Abuse and Mental Health Services Administration (2011) The treatment of depression in older adults: depression and older adults: key issues. Services DoHaH, (ed). Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. US Department of Health and Human Services AIDS.gov
- Wendelken LA, Valcour V (2012) Impact of HIV and aging on neuropsychological function. J Neuro-Oncol 18:256–263Google Scholar